PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Phenobarbital - Epilepsy
PAD Profile : Phenobarbital - Epilepsy Important
Important Information :
Ensure that the patient is maintained on a specific manufacturer’s product
Traffic Light Status
Status 1 of 2.
Status :
Blue
Formulations :
- Elixir
- Tablets
Trust Alignment :
Primary Care
ASPH
RSCH
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Status :
Blue
Important
Formulations :
- Liquid
Important Information :
Unlicensed phenobarbital liquid 50mg/5ml (sugar and alcohol free) for paediatric use (as recommended by the RCPCH and NPPG).
Trust Alignment :
Primary Care
ASPH
RSCH
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
- Eslicarbazepine acetate
- Carbamazepine
- Clobazam
- Lacosamide
- Clonazepam
- Perampanel
- Ethosuximide
- Felbamate
- Rufinamide
- Gabapentin
- Stiripentol
- Lamotrigine
- Zonisamide
- Levetiracetam
- Oxcarbazepine
- Piracetam
- Phenytoin
- Pregabalin
- Topiramate
- Sodium valproate
- Brivaracetam
- Sodium valproate
- Cannabidiol
- Vigabatrin
- Cenobamate
- Primidone
- Tiagabine
Other Indications
Additional Documents
Type
Document
Review Date
Guidelines (National)
01 April 2021
Committee Recommendations
Date
Committee Name
Narrative
04 April 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
he PCN supported the principles of switching from brand to generic medications (not recommended in the elderly) as per national guidelines in September 2013 and the proposed place in therapy of the anti-epileptic drugs which is based on NICE guidance was also discussed at that time. Transfer of care documents will be considered at a future PCN.
Please note the MHRA categorisations for each drug in the attached guidance (updated January 2014) and in the link below.
Associated BNF Codes
04. Central Nervous System
04.08.01. Control of epilepsy